Literature DB >> 22418244

Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data.

María S Degese1, Javier E Mendizabal, Norberto A Gandini, J Silvio Gutkind, Alfredo Molinolo, Stephen M Hewitt, Alejandro C Curino, Omar A Coso, María M Facchinetti.   

Abstract

While changes in heme oxygenase (HO-1) in lung cancer have already been reported, conflicting results were obtained for enzyme expression in human lung cancer specimens. Therefore, the aim of this work was to study HO-1 expression in a large collection of human lung cancer samples. For this purpose, we analyzed the expression of HO-1 in an organized tissue microarray (TMA) and investigated its correlation with clinicopathological data. Ninety-six percent of tumor samples were positive for HO-1, and the expression of HO-1 was significantly higher in cancerous than in non-cancerous tissues. Importantly, HO-1 expression correlated with advanced stages and lymph node involvement. Additionally, quantitative RT-PCR in 18 pairs of human lung carcinomas and their adjacent non-malignant tissues was performed. Our results demonstrate that HO-1 protein is upregulated in epithelial malignant cells in NSCLC and its expression is associated with higher stages of the disease. Additionally, different subcellular localization is observed between tumor and adjacent non-malignant tissues.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22418244     DOI: 10.1016/j.lungcan.2012.02.016

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  29 in total

1.  Heme oxygenase promotes B-Raf-dependent melanosphere formation.

Authors:  Kimberly J Jasmer; Jie Hou; Philip Mannino; Jianlin Cheng; Mark Hannink
Journal:  Pigment Cell Melanoma Res       Date:  2020-07-09       Impact factor: 4.693

2.  High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells.

Authors:  Z Zhao; Y Xu; J Lu; J Xue; P Liu
Journal:  Clin Transl Oncol       Date:  2017-08-14       Impact factor: 3.405

3.  High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients.

Authors:  Jong-Rung Tsai; Hui-Min Wang; Po-Len Liu; Yung-Hsiang Chen; Ming-Chan Yang; Shah-Hwa Chou; Yu-Jen Cheng; Wei-Hsian Yin; Jhi-Jhu Hwang; Inn-Wen Chong
Journal:  Cell Oncol (Dordr)       Date:  2012-10-10       Impact factor: 6.730

Review 4.  Heme oxygenase in neonatal lung injury and repair.

Authors:  Phyllis A Dennery
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

5.  Non-competitive heme oxygenase-1 activity inhibitor reduces non-small cell lung cancer glutathione content and regulates cell proliferation.

Authors:  Mariarita Spampinato; Giuseppe Sferrazzo; Valeria Pittalà; Michelino Di Rosa; Luca Vanella; Loredana Salerno; Valeria Sorrenti; Giuseppe Carota; Nunziatina Parrinello; Marco Raffaele; Daniele Tibullo; Giovanni Li Volti; Ignazio Barbagallo
Journal:  Mol Biol Rep       Date:  2020-02-13       Impact factor: 2.316

6.  Pathological significance and prognostic implications of heme oxygenase 1 expression in non-muscle-invasive bladder cancer: Correlation with cell proliferation, angiogenesis, lymphangiogenesis and expression of VEGFs and COX-2.

Authors:  Tomohiro Matsuo; Yasuyoshi Miyata; Kensuke Mitsunari; Takuji Yasuda; Kojiro Ohba; Hideki Sakai
Journal:  Oncol Lett       Date:  2016-11-22       Impact factor: 2.967

7.  Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma.

Authors:  Norberto A Gandini; María E Fermento; Débora G Salomón; Diego J Obiol; Nancy C Andrés; Jean C Zenklusen; Julián Arevalo; Jorge Blasco; Alejandro López Romero; María M Facchinetti; Alejandro C Curino
Journal:  Tumour Biol       Date:  2014-03

8.  Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.

Authors:  Shujie Song; Vinh Nguyen; Travis Schrank; Kathleen Mulvaney; Vonn Walter; Darmood Wei; Tess Orvis; Nisarg Desai; Jiren Zhang; D Neil Hayes; Yanfang Zheng; Michael B Major; Bernard E Weissman
Journal:  Mol Cancer Res       Date:  2020-08-27       Impact factor: 5.852

Review 9.  Heme oxygenase-1: a metabolic nike.

Authors:  Barbara Wegiel; Zsuzsanna Nemeth; Matheus Correa-Costa; Andrew C Bulmer; Leo E Otterbein
Journal:  Antioxid Redox Signal       Date:  2014-02-27       Impact factor: 8.401

Review 10.  Clinical Significance of Heme Oxygenase 1 in Tumor Progression.

Authors:  Mariapaola Nitti; Caterina Ivaldo; Nicola Traverso; Anna Lisa Furfaro
Journal:  Antioxidants (Basel)       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.